Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review

Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review

Abstract Background Quantitative molecular imaging via single-photon emission computed tomography-derived standardised uptake value (SPECT/CT-SUV) is used to assess the response of metastatic castration-resistant prostate cancer (mCRPC) patients to targeted radionuclide therapy (TRT) with [177Lu]Lu-...

Full description

Saved in:

Bibliographic Details
Main Author:	Tahani O. Alkahtani
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Medical Imaging
Subjects:	177Lu-PSMA 68 Ga-PSMA Quantitative SPECT/CT Standardised uptake value Prostate cancer Targeted radionuclide therapy
Online Access:	https://doi.org/10.1186/s12880-025-01571-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
by: K. Pełka, et al.
Published: (2025-01-01)

Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
by: Pete Tually, et al.
Published: (2024-12-01)

Outcome of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Progressive Metastatic Neuroendocrine Tumors from a Tertiary Care Center
by: David Mathew, et al.
Published: (2024-12-01)

Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
by: Ilham Badrane, et al.
Published: (2024-12-01)

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
by: Theresa Jung, et al.
Published: (2025-01-01)

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01)

Incidental discovery of gastrointestinal stromal tumor via PSMA-PET/CT imaging: Insights from a case report
by: Venetia A. Florou, et al.
Published: (2025-01-01)

Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT: a comparison to MRI using histopathology as reference
by: Erland Hvittfeldt, et al.
Published: (2025-01-01)

Internal Dosimetry in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-[DOTA0-Tyr3] Octerotate: A Single-Center Experience
by: Elahe Mahmoudi, et al.
Published: (2025-01-01)

Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
by: Aaron R. Hansen, et al.
Published: (2025-01-01)

Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapy
by: Myrna Luna-Gutiérrez, et al.
Published: (2025-01-01)

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
by: Junjie Fan, et al.
Published: (2025-02-01)

Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
by: Marco M. E. Vogel, et al.
Published: (2025-01-01)

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study
by: Jisce R. Puik, et al.
Published: (2025-01-01)

Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews [version 2; peer review: 2 approved]
by: Susan Ahern, et al.
Published: (2025-01-01)

Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
by: Ana Rodríguez-Pajuelo, et al.
Published: (2025-02-01)

The impact of preliminary patient hydration on physiological [18F]PSMA-1007 uptake in the urinary bladder on PET/CT
by: T. L. Antonevskaya, et al.
Published: (2024-06-01)

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands
by: Cesare Michele Iacovitti, et al.
Published: (2025-01-01)

Evaluating [<sup>68</sup>Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study
by: Andrea Di Giorgio, et al.
Published: (2024-12-01)

PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny
by: Mohammad A. Alzubi, et al.
Published: (2025-02-01)

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy
by: Turgut Bora Cengiz, et al.
Published: (2025-01-01)

Count-rate management in 131I SPECT/CT calibration
by: Staffan Jacobsson Svärd, et al.
Published: (2025-01-01)

Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?
by: Tiberiu Damian, et al.
Published: (2024-11-01)

Assessing SPECT/CT for the identification of cartilage lesions in the knee joint: A systematic review
by: Larissa Rix, et al.
Published: (2025-03-01)

Detection Performance of 99mTc in Albira SI Small-Animal SPECT-CT
by: Jie TANG, et al.
Published: (2025-02-01)

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01)

Impact of 68Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer
by: Shunyu Zhang, et al.
Published: (2025-01-01)

68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism
by: MengDan Li, et al.
Published: (2025-01-01)

The SwiftScan step-and-shoot continuous mode improves SPECT scanning efficiency: a preliminary phantom and clinical test
by: Jicheng Li, et al.
Published: (2025-01-01)

Monitoring of radionuclides in carbon steel blooms produced by EAF process
by: Sofilić T., et al.
Published: (2011-01-01)

On the reduction of imaging time-points for dosimetry in radionuclide therapy
by: Johan Gustafsson, et al.
Published: (2025-02-01)

99m 锝标记前列腺癌PSMA适配体的制备和临床前研究
by: 吕殷婷, et al.
Published: (2017-01-01)

68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study
by: Yilin Li, et al.
Published: (2025-01-01)

Radionuclide contamination in agricultural and urban ecosystems: A study of soil, plant, and milk samples
by: Aichouche Mohamed E.A., et al.
Published: (2024-01-01)

Fully Automated Production of (((<i>S</i>)-1-Carboxy-5-(6-([<sup>18</sup>F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-<span style="font-variant: small-caps">l</span>-glutamic Acid ([<sup>18</sup>F]JK-PSMA-7)
by: Philipp Krapf, et al.
Published: (2025-01-01)

A review of state-of-the-art resolution improvement techniques in SPECT imaging
by: Zhibiao Cheng, et al.
Published: (2025-01-01)

Filters Effect on Image Quality of 177Lu-DOTATATE SPECT Images for Neuro-Endocrine Tumors Scanning
by: Hussein Dakhil, et al.
Published: (2025-01-01)

On the Effect of the Patient Table on Attenuation in Myocardial Perfusion Imaging SPECT
by: Tamino Huxohl, et al.
Published: (2025-01-01)

Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography
by: Marc Pretze, et al.
Published: (2024-12-01)

Radiation hazards from natural radionuclides contained in rice from former tin mining land
by: J. Mellawati, et al.
Published: (2024-11-01)